This department is offering a grant opportunity to develop cancer prevention, diagnosis, or treatment technologies for low- and middle-income countries as well as low-resource settings in the US. Small Business Innovation Research grant applications are encouraged to create user-friendly and affordable products for cancer prevention and treatment in remote or underserved populations. The focus is on technologies like vaccine dissemination tools, imaging devices, and in vitro diagnostic tools that can address pre-cancerous or cancerous lesions in low-resource settings. Emphasis is on technologies that provide immediate treatment options available within the local health systems.
Opportunity ID: 305559
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-802 |
| Funding Opportunity Title: | Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 – Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 24, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jan 05, 2021 |
| Current Closing Date for Applications: | Jan 05, 2021 |
| Archive Date: | Feb 10, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. see the funding opportunity for the eligibility details |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (STTR) grant applications from small business concerns (SBCs) proposing commercially-directed research for the development of cancer prevention, diagnosis, or treatment technologies to improve cancer outcomes in low- and middle-income countries (LMICs), and low-resource settings in the US. Specifically, the FOA solicits encourages grant applications from SBCs to develop or adapt, apply, and validate existing or emerging technologies into user-friendly products for cancer prevention, diagnosis, or treatment in low-resource settings. These technologies should be practical and affordable in the low-resource settings, including remote or underserved populations within or outside the US. The technologies may include, but are not limited to tools for vaccine dissemination/delivery, imaging, in vitro diagnosis, or treatment of pre-cancerous (pre-neoplastic) or cancerous lesions that are preventable or treatable within low-resource settings. Strong emphasis is placed on technologies that directly provide or immediately lead to treatment options available in the local health system. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-802.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00242504 | Aug 05, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00260260 | Aug 05, 2018 | Jan 05, 2021 | View |
Package 1
Mandatory forms
305559 RR_SF424_2_0-2.0.pdf
305559 PHS398_CoverPageSupplement_4_0-4.0.pdf
305559 RR_OtherProjectInfo_1_4-1.4.pdf
305559 PerformanceSite_2_0-2.0.pdf
305559 RR_KeyPersonExpanded_2_0-2.0.pdf
305559 RR_Budget_1_4-1.4.pdf
305559 RR_SubawardBudget30_1_4-1.4.pdf
305559 PHS398_ResearchPlan_4_0-4.0.pdf
305559 SBIR_STTR_Information_1_2-1.2.pdf
Optional forms
305559 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
305559 RR_SF424_2_0-2.0.pdf
305559 PHS398_CoverPageSupplement_5_0-5.0.pdf
305559 RR_OtherProjectInfo_1_4-1.4.pdf
305559 PerformanceSite_2_0-2.0.pdf
305559 RR_KeyPersonExpanded_2_0-2.0.pdf
305559 RR_Budget_1_4-1.4.pdf
305559 RR_SubawardBudget30_1_4-1.4.pdf
305559 PHS398_ResearchPlan_4_0-4.0.pdf
305559 SBIR_STTR_Information_1_3-1.3.pdf
305559 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
305559 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
